We are live on ! Find out more
CWM

Centric Wealth Management Portfolio holdings

AUM $501M
1-Year Est. Return 15.27%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+15.27%
3 Year Est. Return
+36.23%
5 Year Est. Return
+58.79%
10 Year Est. Return
AUM
$289M
AUM Growth
-$61.4M
Cap. Flow
-$93.1M
Cap. Flow %
-32.21%
Top 10 Hldgs %
50.24%
Holding
227
New
14
Increased
53
Reduced
75
Closed
76

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$5.01M
2
COTY icon
Coty
COTY
+$3.63M
3
RORO
ATAC US Rotation ETF
RORO
+$2.29M
4
CRWD icon
CrowdStrike
CRWD
+$1.44M
5
NVDA icon
NVIDIA
NVDA
+$1.04M

Top Sells

Rank Stock Value
1
ATRS
Antares Pharma, Inc.
ATRS
+$13.7M
2
GE icon
GE Aerospace
GE
+$6.19M
3
PLTR icon
Palantir
PLTR
+$5.25M
4
BAC icon
Bank of America
BAC
+$4.91M
5
C icon
Citigroup
C
+$4.81M

Sector Composition

Rank Sector Weight
1 Industrials 32.53%
2 Technology 10.86%
3 Healthcare 8.11%
4 Consumer Staples 7.29%
5 Consumer Discretionary 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
151
CALL
Abbott
ABT
$180B
$2K ﹤0.01%
300
AAP icon
152
Advance Auto Parts
AAP
$3.37B
-4,505
Closed -$827K
APH icon
153
Amphenol
APH
$188B
-6,400
Closed -$211K
ARCC icon
154
Ares Capital
ARCC
$13.5B
-120,000
Closed -$2.25M
AWF
155
AllianceBernstein Global High Income Fund
AWF
$867M
-10,085
Closed -$120K
BCO icon
156
Brink's
BCO
$5.02B
-23,645
Closed -$1.87M
BHC icon
157
CALL
Bausch Health
BHC
$1.65B
-3,000
Closed -$23K
BHC icon
158
Bausch Health
BHC
$1.65B
-77,000
Closed -$2.44M
BMY icon
159
CALL
Bristol-Myers Squibb
BMY
$127B
-5,000
Closed -$23K
BMY icon
160
Bristol-Myers Squibb
BMY
$127B
-48,458
Closed -$3.06M
BW icon
161
Babcock & Wilcox
BW
$1.43B
-41,295
Closed -$391K
C icon
162
Citigroup
C
$222B
-66,113
Closed -$4.81M
CBOE icon
163
Cboe Global Markets
CBOE
$29.8B
-2,235
Closed -$221K
CGC
164
Canopy Growth
CGC
$375M
-3,888
Closed -$1.25M
CHW
165
Calamos Global Dynamic Income Fund
CHW
$544M
-45,574
Closed -$466K
CLF icon
166
Cleveland-Cliffs
CLF
$6.81B
-159,000
Closed -$3.2M
CRI icon
167
Carter's
CRI
$1.43B
-13,570
Closed -$1.21M
CSQ icon
168
Calamos Strategic Total Return Fund
CSQ
$3.21B
-31,223
Closed -$538K
CSWC icon
169
Capital Southwest
CSWC
$1.46B
-36,000
Closed -$798K
DBX icon
170
Dropbox
DBX
$6.81B
-43,500
Closed -$1.16M
DIV icon
171
Global X SuperDividend US ETF
DIV
$787M
-17,943
Closed -$348K
DWLD icon
172
Davis Select Worldwide ETF
DWLD
$586M
-9,224
Closed -$311K
EOI
173
Eaton Vance Enhanced Equity Income Fund
EOI
$808M
-14,875
Closed -$250K
F icon
174
CALL
Ford
F
$57.3B
-10,000
Closed -$26K
F icon
175
Ford
F
$57.3B
-181,956
Closed -$2.23M

Similar funds

Centric Wealth Management's Q2 2021 Portfolio in Review

As of Q2 2021, Centric Wealth Management held 227 positions worth $289M, down 18% from $350M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Centric Wealth Management withdrew a net $93.1M in Q2 2021, closing 76 positions and reducing 75 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 33% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Centric Wealth Management opened a new position in ATAC US Rotation ETF worth $2.35M.

  • Centric Wealth Management's largest Q2 2021 buy was ATAC US Rotation ETF: 98,951 shares worth $2.35M.
  • Centric Wealth Management added most to Energy Transfer Partners in Q2 2021, an estimated $5.01M increase.
  • Centric Wealth Management's biggest Q2 2021 reduction was GE Aerospace, cutting an estimated $6.19M.
  • Centric Wealth Management fully exited Antares Pharma, Inc. in Q2 2021, selling an estimated $13.7M.
  • Centric Wealth Management's ten largest holdings make up 50% of its $289M portfolio in Q2 2021.
  • Centric Wealth Management opened 14 new positions and closed 76 in Q2 2021.
  • Centric Wealth Management's portfolio value fell 18% quarter-over-quarter to $289M.

Based on Centric Wealth Management's 13F filing for Q2 2021, filed 21 Jul 2021.